Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 153 citing articles:

Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 175
The SARS‐CoV‐2 main protease (Mpro): Structure, function, and emerging therapies for COVID‐19
Qing Hu, Yuan Xiong, Guanghao Zhu, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 144
Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts
Zhonglei Wang, Liyan Yang
Journal of Ethnopharmacology (2021) Vol. 270, pp. 113869-113869
Open Access | Times Cited: 135
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
Ashuai Du, Rong Zheng, Cyrollah Disoma, et al.
International Journal of Biological Macromolecules (2021) Vol. 176, pp. 1-12
Open Access | Times Cited: 106
Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products Against COVID-19: Update on Clinical Trials and Mechanism of Actions
Safaet Alam, Md. Moklesur Rahman Sarker, Sadia Afrin, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 104
mRNA vaccines for COVID-19 and diverse diseases
Abid Hussain, Haiyin Yang, Jun Zhang, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 314-333
Open Access | Times Cited: 81
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM
Sai Tian, Jinbo Zhang, Shunling Yuan, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 52
Natural triterpenoids from licorice potently inhibit SARS-CoV-2 infection
Yi Yang, Junhua Li, Xinyuan Lai, et al.
Journal of Advanced Research (2021) Vol. 36, pp. 201-210
Open Access | Times Cited: 91
Insight into chemical basis of traditional Chinese medicine based on the state-of-the-art techniques of liquid chromatography−mass spectrometry
Yu Yang, Changliang Yao, De‐an Guo
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 6, pp. 1469-1492
Open Access | Times Cited: 85
Research progress of traditional Chinese medicine against COVID-19
Wei Ren, Pan Liang, Yue Ma, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111310-111310
Open Access | Times Cited: 69
A review of pharmacological and pharmacokinetic properties of Forsythiaside A
Lihong Gong, Cheng Wang, Honglin Zhou, et al.
Pharmacological Research (2021) Vol. 169, pp. 105690-105690
Closed Access | Times Cited: 63
Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
Yi Yang, Meng Zhang, Heng Xue, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4154-4164
Open Access | Times Cited: 53
Emerging biotechnology applications in natural product and synthetic pharmaceutical analyses
Shilin Chen, Zheng Li, Sanyin Zhang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4075-4097
Open Access | Times Cited: 45
Screening of immune cell activators from Astragali Radix using a comprehensive two-dimensional NK-92MI cell membrane chromatography/C18 column/time-of-flight mass spectrometry system
Xinyi Chai, Yanqiu Gu, Lei Lv, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 12, Iss. 5, pp. 725-732
Open Access | Times Cited: 39
Screening and evaluation of anti-SARS-CoV-2 components from Ephedra sinica by ACE2/CMC-HPLC-IT-TOF-MS approach
Yanni Lv, Saisai Wang, Peida Liang, et al.
Analytical and Bioanalytical Chemistry (2021) Vol. 413, Iss. 11, pp. 2995-3004
Open Access | Times Cited: 45
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19
Khan Sharun, Ruchi Tiwari, Mohd I. Yatoo, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e92-e92
Open Access | Times Cited: 34
Recent advances in cell membrane-coated technology for drug discovery from natural products
Yusi Bu, Qi Hu, Tao Bao, et al.
TrAC Trends in Analytical Chemistry (2022) Vol. 151, pp. 116601-116601
Closed Access | Times Cited: 32
Unraveling the mystery of efficacy in Chinese medicine formula: New approaches and technologies for research on pharmacodynamic substances
Yaolei Li, Zhijian Lin, Yu Wang, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 11, pp. 104302-104302
Open Access | Times Cited: 32
Multi-omics approaches for in-depth understanding of therapeutic mechanism for Traditional Chinese Medicine
Xue Zhu, Qi Yao, Pengshuo Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography
Yanqiu Gu, Rong Wang, Panpan Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3682-3693
Open Access | Times Cited: 31
Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19
Bo Zhang, Fanghua Qi
BioScience Trends (2023) Vol. 17, Iss. 1, pp. 14-20
Open Access | Times Cited: 15
Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation
Jinrui Wei, Xuqi Zhao, Fuli Long, et al.
Gene (2024) Vol. 912, pp. 148383-148383
Closed Access | Times Cited: 6
In silico identification of potential phytochemical inhibitors for mpox virus: molecular docking, MD simulation, and ADMET studies
Sudeep D. Ghate, Larina Pinto, Shivakiran Alva, et al.
Molecular Diversity (2024) Vol. 28, Iss. 6, pp. 4067-4086
Closed Access | Times Cited: 5
Uncovering the covalent inhibitors of SARS-CoV-2 Mpro in Tibetan edible herb Rhodiola crenulata and their synergistic anti-Mpro mechanism
Guanghao Zhu, Yani Zhang, Yuan Xiong, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101224-101224
Open Access
Page 1 - Next Page

Scroll to top